PF11 inhibits microglia-mediated neuroinflammation by inactivating NF-κB, Akt, MAPKs pathways

被引:0
|
作者
Wang, Xiao-xiao [1 ]
Zhao, Si-qi [1 ]
Wang, Chun-ming [1 ]
Zhang, Wei [1 ]
Zhang, Yu-chen [1 ]
Wu, Chun-fu [1 ]
Yang, Jing-yu [1 ]
机构
[1] Shenyang Pharmaceut Univ, Dept Pharmacol, Shenyang 110016, Peoples R China
来源
ACTA PHARMACOLOGICA SINICA | 2013年 / 34卷
关键词
PF11; microglia; inflammation; NF-kappa B; MAPK;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:134 / 134
页数:1
相关论文
共 50 条
  • [31] Amentoflavone Inhibits Osteoclastogenesis and Wear Debris-Induced Osteolysis via Suppressing NF-κB and MAPKs Signaling Pathways
    Zhang, Zhen
    Zhao, Shuai
    Li, Xiaolei
    Zhuo, Xiaoqi
    Zhang, Wu
    Nie, Qian
    Wang, Shuguang
    Yan, Lianqi
    Sun, Yu
    PLANTA MEDICA, 2018, 84 (11) : 759 - 767
  • [32] ACT001 attenuates microglia-mediated neuroinflammation after traumatic brain injury via inhibiting AKT/NFκB/NLRP3 pathway
    Cai, Lin
    Gong, Qiuyuan
    Qi, Lin
    Xu, Tongtong
    Suo, Qian
    Li, Xiang
    Wang, Wei
    Jing, Yao
    Yang, Dianxu
    Xu, Zhiming
    Yuan, Fang
    Tang, Yaohui
    Yang, Guoyuan
    Ding, Jun
    Chen, Hao
    Tian, Hengli
    CELL COMMUNICATION AND SIGNALING, 2022, 20 (01)
  • [33] Shikonin ameliorates oxidative stress and neuroinflammation via the Akt/ERK/JNK/NF-κB signalling pathways in a model of Parkinson's disease
    Guo, Lei
    Li, Yuanyuan
    Li, Wenna
    Qiu, Jiaoxue
    Du, Juan
    Wang, Lingling
    Zhang, Ting
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2022, 49 (11) : 1221 - 1231
  • [34] Effective inhibition of melanoma by BI-69A11 is mediated by dual targeting of the AKT and NF-κB pathways
    Feng, Yongmei
    Barile, Elisa
    De, Surya K.
    Stebbins, John L.
    Cortez, Apple
    Aza-Blanc, Pedro
    Villanueva, Jessie
    Heryln, Meenhard
    Krajewski, Stan
    Pellecchia, Maurizio
    Ronai, Ze'ev A.
    Chiang, Gary G.
    PIGMENT CELL & MELANOMA RESEARCH, 2011, 24 (04) : 703 - 713
  • [35] ANGPTL2 deletion inhibits osteoclast generation by modulating NF-κB/MAPKs/Cyclin pathways
    Li, Wei-Ming
    Han, Chen-Long
    Liu, Chen
    Xing, Hai-Yang
    Ding, De-Chen
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 503 (03) : 1471 - 1477
  • [36] Gomisin A inhibits lipopolysaccharide-induced inflammatory responses in N9 microglia via blocking the NF-κB/MAPKs pathway
    Wang, Xiaoxiao
    Hu, Di
    Zhang, Lijia
    Lian, Guoning
    Zhao, Siqi
    Wang, Chunming
    Yin, Jun
    Wu, Chunfu
    Yang, Jingyu
    FOOD AND CHEMICAL TOXICOLOGY, 2014, 63 : 119 - 127
  • [37] α-linolenic acid mitigates microglia-mediated neuroinflammation of schizophrenia in mice by suppressing the NF-κB/NLRP3 pathway via binding GPR120-R-arrestin 2
    Wang, Ting
    Liu, Shudan
    Shen, Wenke
    Liu, Jian
    Liu, Yuanyuan
    Li, Yiwei
    Zhang, Feng
    Li, Ting
    Zhang, Xiaoxu
    Tian, Wenyan
    Zhang, Jiani
    Ma, Junbai
    Guo, Yamei
    Mi, Xiaojuan
    Lin, Yuan
    Hu, Qikuan
    Zhang, Xiaoxia
    Liu, Juan
    Wang, Hao
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 142
  • [38] Wogonoside alleviates microglia-mediated neuroinflammation via TLR4/ MyD88/NF- κB signaling axis after spinal cord injury
    Zhu, Ruyi
    Zhang, Yaling
    He, Weitai
    Sun, Yanan
    Zhao, Xin
    Yan, Yaping
    Zhang, Qian
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 973
  • [39] Abrocitinib Attenuates Microglia-Mediated Neuroinflammation after Traumatic Brain Injury via Inhibiting the JAK1/STAT1/NF-κB Pathway
    Li, Tuo
    Li, Lei
    Peng, Ruilong
    Hao, Hongying
    Zhang, Hejun
    Gao, Yalong
    Wang, Cong
    Li, Fanjian
    Liu, Xilei
    Chen, Fanglian
    Zhang, Shu
    Zhang, Jianning
    CELLS, 2022, 11 (22)
  • [40] Baicalin mitigates cognitive impairment and protects neurons from microglia-mediated neuroinflammation via suppressing NLRP3 inflammasomes and TLR4/NF-κB signaling pathway
    Jin, Xin
    Liu, Ming-Yan
    Zhang, Dong-Fang
    Zhong, Xin
    Du, Ke
    Qian, Ping
    Yao, Wei-Fan
    Gao, Hua
    Wei, Min-Jie
    CNS NEUROSCIENCE & THERAPEUTICS, 2019, 25 (05) : 575 - 590